Kellogg Cancer Center Patient
Leukemia is a cancer of the blood and bone marrow (also referred to as a hematologic malignancy) in which the marrow often can no longer produce enough normal red and white blood cells and platelets (the blood cells that prevent bleeding). Approximately 43,000 cases of the various types of leukemia are estimated to be diagnosed yearly.
Leukemia is divided into four major categories:
The signs and symptoms for leukemia are often vague, but may include fatigue, repeated infections, lasting low-grade fever, bruising easily, and nosebleeds or other hemorrhages.
Leukemia Screening & Diagnosis
There is no established screening for any type of leukemia. Because symptoms often resemble those of other less serious conditions, leukemia can be difficult to diagnose early. Symptomatic patients may undergo a variety of pathology tests, which may include blood tests, and a bone marrow biopsy and aspirate.
There is no standard staging system for leukemia. Untreated, in remission, or recurrent are terms used to describe the status of the disease.
NorthShore University HealthSystem physicians and the team at the Kellogg Cancer Center work collaboratively and are dedicated to putting patients and families at the center of a healthcare experience that delivers compassionate, quality care.
Every week, our multidisciplinary team meets to discuss each patient’s case in detail and to design a personalized treatment plan. Your team may include your hematologist, nurse, genetics counselor, pathologist, nutritionist, interventional radiologist, and researchers focused on you. This meeting of the minds provides each patient with an individualized care plan to create the path for the most optimal outcome. Our approach emphasizes open communication, collaborating with each other personally, and through one of the most advanced electronic medical records systems in the country.